Method for promoting bone regeneration
By irradiating plasma to fracture or bone defect sites, the method effectively addresses bone nonunion issues, enhancing bone regeneration and reducing treatment duration.
Patent Information
- Application Number
- JP2020139761
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-08-21
- Publication Date
- 2025-01-21
- Estimated Expiration
- 2040-08-21
AI Technical Summary
Existing treatments for fractures and bone defects often result in bone nonunion, leading to residual pain, functional impairment, and significant medical economic loss, with a reported incidence of 5-10% bone nonunion after fracture treatment.
A method involving specifying the fracture or bone defect site and irradiating plasma under atmospheric pressure using a plasma generation unit to promote bone regeneration, utilizing a plasma jet to supply active species directly to the site.
The method significantly enhances bone regeneration efficiency by promoting bone formation and union, reducing treatment duration and minimizing complications.
Smart Images

Figure 0007618197000001 
Figure 0007618197000002 
Figure 0007618197000003
Abstract
Description
[Technical field]
[0001] The present invention relates to methods and devices for promoting bone regeneration at the site of a fracture or bone defect. [Background technology]
[0002] In the treatment of fractures, the fractured bone fragments are returned to their original positions and the fractured portion is fixed using a cast in conservative treatment or an implant in surgical treatment (see, for example, Patent Document 1). The period until the bone heals thereafter is an important factor in the regenerative ability inherent to the bone. Similarly, in the treatment of bone defects due to disease or trauma, the key is how to effectively draw out the regenerative ability inherent to the bone, and various basic and clinical studies are being conducted. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2011-229908 A Summary of the Invention [Problem to be solved by the invention]
[0004] If bone regeneration can be promoted in the treatment of fractures and bone defects, it will be possible to suppress the incidence of bone union failure and shorten the treatment period. In this regard, a study calculated based on a US insurance database reported that the incidence of bone union failure after fracture treatment is 5-10%. It is known that the severity of the fracture site, that is, the complexity of the fracture and the presence of bone defects, have a significant impact on bone union. The occurrence of bone union failure not only leads to residual pain and functional impairment, but also causes a large loss to the medical economy. In this context, the inventors realized that they could make a significant contribution to the medical field by providing technology that enhances the efficiency of bone regeneration through medical engineering collaboration.
[0005] The present invention has been made in view of the above problems, and one of its objects is to provide a technique for improving the efficiency of bone regeneration at the site of a fracture or bone defect. [Means for solving the problem]
[0006] One aspect of the present invention is a method for promoting bone regeneration, which includes a target site identifying step of identifying a site of fracture or bone defect, and a plasma supplying step of irradiating plasma toward the site under atmospheric pressure.
[0007] Another aspect of the present invention is a bone regeneration promoting device comprising a gas supply unit that supplies a carrier gas under atmospheric pressure toward a site of a fracture or bone defect, and a plasma generating unit that generates plasma in a supply path of the carrier gas. Effect of the Invention
[0008] According to the present invention, a technique for improving the efficiency of bone regeneration at the site of a fracture or bone defect can be provided. [Brief description of the drawings]
[0009] [Figure 1] 1 is a diagram showing a schematic configuration of a bone regeneration promoting device according to an embodiment. [Diagram 2] FIG. 2 is a diagram showing a distribution tendency of active species contained in a plasma jet. [Diagram 3] FIG. 1 is a schematic diagram showing a method for promoting bone regeneration. [Figure 4] FIG. 13 is a diagram showing an example of an experiment for verifying the bone regeneration promoting effect according to an embodiment. [Diagram 5] FIG. 13 is a diagram showing an X-ray image of the area around the target site 8 weeks after surgery. [Figure 6] FIG. 13 shows micro-CT images of the area around the target site 8 weeks after surgery. [Figure 7] FIG. 13 shows a stained image of the area around the target site 8 weeks after surgery. [Figure 8] FIG. 13 is a diagram showing the effect of plasma exposure time on bone regeneration. [Figure 9]FIG. 13 is a diagram showing the modifying effect of biological bone by plasma irradiation. [Figure 10] FIG. 13 is a diagram showing the modifying effect of biological bone by plasma irradiation. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings. In this embodiment, by directly irradiating plasma to a fractured or defective site of a living bone (hereinafter also referred to as a "target site"), bone formation is promoted in the target site, and bone regeneration efficiency is improved. The method and device are specifically described below.
[0011] FIG. 1 is a diagram showing a schematic configuration of a bone regeneration promoting device according to an embodiment. The bone regeneration promotion device 1 includes a plasma device 10, a gas supply device 12, and a control unit 14. The plasma device 10 functions as a "plasma supply unit" and includes a gas supply pipe 20 through which a carrier gas flows, an electrode 22 provided along the gas supply pipe 20, and a voltage application device 24 that applies a voltage to the electrode 22.
[0012] The gas supply pipe 20 is a cylindrical glass tube (dielectric) with a bottom, and has a tapered tip opening. That is, the tip of the gas supply pipe 20 is formed into a hemispherical shape, and a small-diameter outlet 26 for discharging the carrier gas is provided at the tip. The outlet 26 has an aperture diameter φ of 500 to 700 μm (about 650 μm in this embodiment) and is located on the axis of the gas supply pipe 20. It is known that bone has a porous structure, and the diameter of the gap (porous) in normal bone is 200 to 500 μm. The aperture diameter φ of the outlet 26 is set to be equal to or slightly larger than the gap. The rear end opening of the gas supply pipe 20 serves as an inlet for the carrier gas, and a gas tube 28 of the gas supply device 12 is connected thereto.
[0013] The electrode 22 is disposed along the outer circumferential surface of the gas supply pipe 20. The electrode 22 is a high-voltage electrode disposed coaxially with the gas supply pipe 20, and is connected to a voltage application device 24. With a carrier gas being supplied to the gas supply pipe 20, the voltage application device 24 applies a low-frequency pulse voltage (several kV to 10 kV) of about 10 kHz to the electrode 22 to generate a non-equilibrium plasma jet. This plasma jet PJ is a so-called microplasma, and is discharged linearly from the discharge port 26.
[0014] The plasma jet PJ is a localized discharge region accompanied by light emission that is periodically ejected from the outlet 26 (nozzle) of the gas supply pipe 20 and appears as a jet. These localized discharge regions are also called "plasma bullets" because their behavior resembles that of bullets. The movement of these plasma bullets is a mechanism in which an ionization phenomenon propagates through the flow of a carrier gas that is prone to discharge. The plasma jet PJ can be said to be the carrier gas itself turned into plasma, and can directly irradiate the target object with plasma.
[0015] A housing 29 is provided so as to cover the gas supply pipe 20 and the electrode 22. The housing 29 is made of a resin such as polytetrafluoroethylene (PTFE) and has insulating properties. The housing 29 is configured to be palm-sized.
[0016] The gas supply device 12 functions as a "gas supply section" and supplies a carrier gas to the plasma device 10. The carrier gas is a gas that propagates plasma, and in this embodiment, helium gas (He) is used. The gas supply device 12 has a gas tank 30. The gas tank 30 is connected to a pipe 32, and a gas tube 28 is connected to the tip of the pipe 32. A control valve 34 is provided on the pipe 32. When the control valve 34 is opened, the carrier gas is supplied to the plasma device 10.
[0017] The control unit 14 is made up of a microcomputer having a CPU, ROM, RAM, etc., and performs power supply control of the plasma device 10 and drive control of the gas supply device 12 (opening and closing control of the control valve 34). An input device (not shown) is connected to the control unit 14. Based on operation input by the user via the input device, the control unit 14 executes various controls.
[0018] Fig. 2 shows the distribution tendency of active species contained in the plasma jet. The upper part of the figure shows a visualized image of the plasma jet PJ, and the middle and lower parts show the distribution of active species. The middle part shows positive ions, and the lower part shows negative ions. In each figure, the horizontal axis shows the distance from the outlet 26, and the vertical axis shows the amount (intensity) of active species.
[0019] The high-intensity portion of the plasma jet PJ contains many charged particles. The charged particles are reduced downstream of the plasma jet PJ (such as the dashed line area in the figure), and many neutral active species (active oxygen species and active nitrogen species) are contained (not shown). In this embodiment, the active species downstream of the plasma jet PJ (downstream of the dashed line in the figure) are actively supplied to the fracture or bone defect site. In other words, bone regeneration is promoted by supplying plasma with a relatively high proportion of neutral active species compared to the charged particles to the target site (described in detail below).
[0020] FIG. 3 is a schematic diagram showing a method for promoting bone regeneration. In this embodiment, in order to promote bone regeneration at a fractured or bone-defected site, plasma is directly irradiated to a target site X of a living bone B. That is, first, the fractured or bone-defected site is identified as the target site X, and a portion of the skin corresponding to the target site X is incised to expose the target site X from the incision (target site identifying step). Next, a plasma jet PJ is supplied to the target site X (the gap between the bone fragments B1 and B2) while the fractured bone fragments B1 and B2 are repositioned as necessary (plasma supply step). If the fracture is accompanied by a bone defect, the gap becomes larger.
[0021] At this time, in order to efficiently supply the active species (particularly neutral active species such as active oxygen species and active nitrogen species) contained in the plasma jet PJ to the target site X, the plasma device 10 is brought moderately close to the target site X. However, in order to prevent contamination of the living body, the tip of the plasma device 10, i.e., the outlet 26 of the gas supply pipe 20, is adjusted so as to be located outside the periosteum. For example, it may be adjusted so that the tip of the high-intensity part of the plasma jet PJ (see the dashed line in FIG. 2) is located at the position of the periosteum.
[0022] In the example shown in Figure 3, there is a bone defect, and bone tissue is also present at the back of the target site X (on the extension of the plasma jet PJ). This applies when there is a concave bone defect in the living bone B, or when two bones are adjacent to each other as the living bone B. The experimental example described below (relationship between the ulna and radius) corresponds to the latter case. In this case, as shown by the arrow in the figure, the plasma jet PJ is reflected by the bone surface F at the back, and enters and exits while filling the gap.
[0023] Considering the healing mechanism of the fracture or bone defect site, the flow rate and supply time of the plasma jet PJ are kept to a level that does not dry out the target site X. This is to maintain the occurrence of a hematoma associated with bleeding from the bone marrow in the target site X, and to effectively utilize the various growth factors contained in the hematoma for bone regeneration. In this embodiment, the flow rate of the plasma jet PJ is adjusted to about 0.1 to 1 slm. The supply of the plasma jet PJ is set to a time during which capillary bleeding (oozing bleeding) is observed, and the plasma irradiation is stopped before hemostasis or coagulation in the target site X is completed.
[0024] That is, a hematoma is generated at the target site X, and fills the defective area of bone and bone marrow tissue. At this time, growth factors such as TGF-β and PDGF are induced, causing the proliferation of granulation tissue and angiogenesis. Then, the cell proliferation phase begins, and undifferentiated mesenchymal cells and osteoblast precursor cells emerge from the granulation tissue. These cells have the ability to later form bone and cartilage. The granulation tissue formed in the early stage also plays an important role as a scaffold for these cells. For this reason, the formation of a hematoma is very important for bone regeneration.
[0025] In this embodiment, the bone surface at the target site X is modified by plasma irradiation, and the affinity with cells generated during the hematoma formation process (particularly in the early stage of hematoma development) is increased to promote bone regeneration. Below, an example of an experiment conducted to verify the effect will be described.
[0026] 4A and 4B are diagrams showing an example of an experiment for verifying the bone regeneration promoting effect according to an embodiment, in which (A) and (B) are images taken during the experimental process. This experiment was an animal experiment using rabbits as subjects. Several rabbits were prepared, and bone defects were artificially created in the ulna of each rabbit, and the effect of the degree of plasma irradiation on bone regeneration was examined. Specifically, the procedure is as follows.
[0027] A rabbit was given general anesthesia, the skin of the arm was incised, and a bone defect of about 1 cm was created in the diaphysis of the ulna B10 (Figure 4(A)). Behind the ulna B10 is the radius B12. This bone defect corresponds to the target site X. The depth of this bone defect, that is, the distance from the surface of the ulna B10 to the surface of the radius B12, is about 800 μm.
[0028] Plasma was irradiated toward this target site X for a specified period of time (Figure 4(B)). At this time, the supply position of the plasma jet PJ was set to approximately the center of the target site X. The incision was then closed, and bone union was evaluated after 8 weeks. Note that plasma was irradiated only once, and the amount of new bone was compared when the plasma irradiation time was varied to 5 minutes, 10 minutes, and 15 minutes. In addition, as a comparative example, a case where only gas was irradiated without generating plasma using this device (control) was also examined.
[0029] To ensure the reliability of the experimental results, five subjects were used for each of the cases of non-plasma irradiation (control), 5-minute irradiation, 10-minute irradiation, and 15-minute irradiation. For these, bone formation was observed using X-rays and new bone mass was measured using micro-CT. The measurement results were the average of the five subjects. In addition, rabbits of the same age and weight were used as experimental subjects so that individual differences in the subjects could be ignored.
[0030] Specifically, X-rays were taken of the target site X 2, 4, 6, and 8 weeks after surgery to observe the bone regeneration process. Then, 8 weeks after surgery, living bones including the target site X were taken as samples, and the amount of newly formed bone was measured based on micro-CT images. This measurement was performed using software well known in the art, but details will not be explained here. Furthermore, each sample was stained with Masson trichrome stain and histological evaluation was performed.
[0031] Figure 5 shows X-ray images of the area around the target site 8 weeks after surgery. Figure 5(A) shows the case of no plasma irradiation (control), and Figure 5(B) shows the case of plasma irradiation (10 minutes). The area surrounded by the dashed line shows the vicinity of the target site X. From these, it can be seen that in the case of no plasma irradiation, almost no bone formation was observed, whereas in the case of plasma irradiation, the amount of bone formation increased significantly. Although not shown in the figure, in the case of plasma irradiation, the progress of bone regeneration (change over time) could be observed as the time passed 2 weeks, 4 weeks, and 6 weeks after surgery, but in the case of no plasma irradiation, it was hardly observed.
[0032] Figure 6 shows micro-CT images of the area around the target site 8 weeks after surgery. Figure 6(A) shows the case of no plasma irradiation (control), and Figure 6(B) shows the case of plasma irradiation (10 minutes). From these images, it can be seen that in the case of no plasma irradiation, almost no new bone formation was observed, whereas in the case of plasma irradiation, the amount of new bone formation increased significantly.
[0033] In other words, the bone defect created in this experiment corresponds to a critical defect, which will not heal if left untreated. Nevertheless, it can be seen that supplying the plasma jet PJ to the target site X promotes bone regeneration and enables healing.
[0034] Figure 7 shows stained images of the area around the target site 8 weeks after surgery. Figure 7(A) corresponds to the area surrounded by the dashed line in Figure 5(A) and shows the case of non-plasma irradiation (control). Figure 7(B) corresponds to the area surrounded by the dashed line in Figure 5(B) and shows the case of plasma irradiation (10 minutes).
[0035] This stained image was obtained by Masson's trichrome staining, with the white area representing bone marrow BM, the blue area representing bone tissue and other fibrous tissue, and the red area representing muscle fibers, etc. (Color is not displayed in this figure). Figure 7(A) shows that without plasma irradiation, scar tissue ST, such as muscle fibers and collagen fibers, remains at the target site X, inhibiting bone regeneration. On the other hand, Figure 7(B) shows that plasma irradiation results in a significant increase in new bone AT at the target site X. In other words, it can be seen that applying plasma irradiation to the target site X during surgery promotes bone union and promotes bone regeneration.
[0036] Figure 8 shows the effect of plasma exposure time on bone regeneration. The horizontal axis of this figure shows the plasma exposure time. As a comparative example, a case without plasma exposure (control) is also shown. The vertical axis shows the volume of new bone 8 weeks after surgery.
[0037] According to this experiment, it is found that the most new bone was obtained when the plasma jet was supplied for 10 minutes. Specifically, when the plasma was irradiated for 10 minutes, the bone regeneration promotion effect was about 1.5 times greater than when the plasma was not irradiated. One of the reasons for the decrease in the amount of new bone when the plasma was irradiated for 15 minutes is thought to be that the target site was dried out by the spraying of the carrier gas, that is, it became difficult to maintain a moist environment at the target site. For this reason, in this embodiment, the plasma irradiation is stopped within the time when capillary bleeding (oozing bleeding) is observed at the target site.
[0038] Although the optimal plasma exposure time may vary depending on the type of living organism and the amount of plasma jet supplied, this experiment at least demonstrated that there are optimal values for the supply amount (flow rate) and supply time.
[0039] Figures 9 and 10 are diagrams showing the modification effect of biological bone by plasma irradiation. Figure 9 shows an example of an experiment conducted to verify the modification effect. Figure 10 shows the effect of improving hydrophilicity as a function of plasma irradiation time. Figures 10(A) to (D) show the results of dripping distilled water (water droplets) onto biological bone that had been exposed to plasma for 1 minute, 2 minutes, 3 minutes, and 4 minutes, respectively, and then left for a predetermined time (30 seconds). Figure 10(E) shows the case of no plasma irradiation (control) as a comparative example.
[0040] As shown in Figure 9, in this experiment, a plasma jet PJ was irradiated for a predetermined period of time (Figure 9(A)) onto a living bone B20 immediately after removal from a subject (rabbit), and then a water droplet L was dropped onto the plasma-irradiated area (Figure 9(B)), and the change in shape of the water droplet L (change in contact angle) was observed.
[0041] The experimental results show that when plasma was irradiated, the water droplets penetrated into the living bone more easily as the irradiation time increased, causing their shape to collapse (i.e., the contact angle became smaller) (Figures 10 (A) to (D)). After 4 minutes of irradiation, the water droplets became flat, making it impossible to measure the contact angle. On the other hand, when plasma was not irradiated, the shape of the water droplets was maintained and the contact angle did not change.
[0042] The experiment was repeated five times each for non-plasma exposure (control) and plasma exposure (3 minutes), and the average contact angle was approximately 73 degrees for the former and approximately 45 degrees for the latter. In other words, this experiment verified that plasma exposure for a certain period of time or longer can result in a modification effect on living bone (improved hydrophilicity).
[0043] It is possible that the improved hydrophilicity (wettability) caused by plasma irradiation contributes to the promotion of bone regeneration. For example, by increasing the hydrophilicity of the fracture or bone defect site (target site) at the hematoma formation stage, the above-mentioned growth factors contained in the hematoma may be more likely to induce osteoblasts, promoting bone regeneration. In other words, it can be considered that plasma irradiation has an effective effect on the hematoma formed in the bone defect site as an initial traumatic reaction.
[0044] After the above experiment, we investigated what kind of active species the plasma generated and how it activated the biological tissue. Specifically, we performed emission spectroscopy to identify the plasma active species, used a thermography camera to confirm the presence or absence of a thermal effect, and evaluated the degree of hydrophilization of the bone surface. As a result, the generation of OH radicals and excited nitrogen molecules was confirmed. There was no change in the temperature of the surface of the bone defect, and no damage to the biological tissue due to heat was confirmed. The hydrophilicity of the bone tissue surface was improved, and improved adsorption of liquid components in the defect was observed.
[0045] From the above experimental results, it was found that plasma irradiation of the target site X promotes bone union and bone regeneration. It is possible that plasma irradiation had a positive effect on the activation of surrounding cells and tissues (muscle cells, osteoblasts, nerve cells, mesenchymal cells) and on hematoma formation as an early traumatic reaction. It is thought that plasma irradiation directly acts on osteoblasts contained in the periosteum of the target site, promoting their differentiation and proliferation, resulting in accelerated healing.
[0046] As described above, according to this embodiment, when treating a fracture or bone defect site (target site), bone regeneration can be effectively promoted by irradiating the target site with plasma during the process of hematoma formation. By supplying plasma as a plasma jet, active species that contribute to promoting bone regeneration can be pinpointed and directed to a specific location in the target site. In other words, highly reactive plasma can be sent to the target position (target).
[0047] In addition, by adjusting the flow rate of the plasma jet according to the size of the target site, the target site can be prevented from drying out, and the growth factors contained in the hematoma can be made to function effectively in bone regeneration. The plasma treatment of this embodiment only needs to be used once during surgery or immediately before suturing surgery, which allows the target site to be expected to recover quickly.
[0048] In addition, by adjusting the length of the plasma jet according to the depth of the target area, active species effective for bone regeneration can be actively supplied to the target area. Furthermore, by adjusting the plasma irradiation time, it is possible to efficiently increase the amount of new bone. It is expected that the bone regeneration promotion effect can be maximized by optimizing the length, flow rate, and irradiation time of the plasma jet.
[0049] Although the preferred embodiment of the present invention has been described above, it goes without saying that the present invention is not limited to the specific embodiment, and various modifications are possible within the scope of the technical concept of the present invention.
[0050] In the above embodiment, the plasma device has a single electrode, but a configuration with multiple electrodes may be adopted. Two electrodes may be disposed along the outer circumferential surface of the gas supply pipe. Alternatively, the plasma device may have an outer electrode disposed on the outer circumferential surface of the gas supply pipe and an inner electrode disposed inside the gas supply pipe.
[0051] In the above embodiment, a cylindrical glass tube with a bottom is exemplified as the gas supply pipe. In a modified example, the tip of the gas supply pipe may be tapered or have another shape. In addition, the material is not limited to glass, and may be any dielectric material.
[0052] In the above embodiment, as an example, a method of irradiating plasma to a target site while reducing a fractured bone fragment has been described. In a modified example, reduction treatment may be performed after irradiating plasma to the target site. As shown in the above experimental example, reduction treatment may not be necessary depending on the location of a fracture or bone defect in a living body. In cases of a fracture without displacement or deformation, a bone defect but continuity is maintained in other areas and the bone shape is maintained, or in cases of bone grafting in spinal surgery (spinal fixation), reduction treatment can be omitted. When transplanting autologous bone, allogeneic bone, artificial bone, or the like to a target site, bone formation can be promoted by irradiating plasma toward the target site (bone graft site).
[0053] In the above embodiment, an example has been shown in which a plasma jet is supplied to a target portion, but plasma not having a jet form may also be irradiated.
[0054] Although not mentioned in the above embodiment, there are cases of delayed healing and pseudoarthrosis, where the healing of a fracture is delayed or does not heal. In treating such delayed healing and pseudoarthrosis, a method may be used in which non-bone tissue (scar, granulation tissue) present in the target area is removed, bleeding from the bone marrow is promoted, and the target area is fixed with an implant. In such cases, good bone regeneration may be achieved by irradiating the target area with plasma at the timing when bleeding from the bone marrow is promoted.
[0055] In the above embodiment, an example was shown in which bone tissue exists deep inside the target site when viewed in the direction of the plasma jet discharge, that is, an example in which the bone surface that serves as a reflective surface for the carrier gas exists on the extension line of the plasma jet. Even if no bone tissue exists deep inside like this, the tissue surfaces of surrounding muscles, ligaments, etc. can function as reflective surfaces. In the above embodiment, low-temperature atmospheric pressure plasma (non-equilibrium plasma jet) is used, so safety to these biological tissues can be ensured. In addition, the distribution of active species generated downstream of the plasma jet has a certain degree of spread from the axis of the plasma jet, so the effect of plasma irradiation can be fully expected.
[0056] In order to achieve the effect more significantly, the plasma jet may be moved within the bone defect area of the target site. In other words, the plasma jet may be scanned in a direction having a perpendicular component to the ejection direction. Such a scanning mechanism may be provided. The control unit 14 may control the scanning mechanism.
[0057] In the above embodiment, the bone regeneration promoting method and device are applied to the field of orthopedics, but they can also be applied to other medical fields such as dental oral surgery and neurosurgery. In the dental oral surgery field, they can also be applied to regenerate bone tissue such as the alveolar bone and jawbone, which serve as a base for embedding an implant. In the dental oral surgery field, bone tissue may be exposed before surgery, and it is expected that the skin incision process will not be necessary. In the above embodiment, the application to animals (non-humans) was shown as an experimental example, but it goes without saying that they can be applied to humans.
[0058] Although not mentioned in the above embodiment, the bone regeneration promoting method and device can be applied not only to fractures caused by trauma, but also to fractures and bone defects caused by osteoporosis.
[0059] In the above embodiment, bone regeneration in the case of bone loss among fractures has been mainly described, but the extent of the effect on fractures without bone loss will have to wait for future research results. That is, bone tissue includes hard cortical bone that forms the vicinity of the bone surface and soft cancellous bone that forms the bone interior. It is not clear at this time which bone tissue the plasma irradiation contributes to more significantly in regeneration.
[0060] In this regard, if there is a bone defect, the plasma will be irradiated to both, so there is not much need to consider which is more important. On the other hand, if the gap at the fracture site is substantially eliminated by reduction, it may not be easy to introduce plasma into the gap while reducing the site. In such a case, it is preferable to set the surgical procedure taking into account the bone regeneration effect of plasma irradiation on the cancellous bone.
[0061] When plasma irradiation contributes greatly to bone regeneration of cancellous bone, it is preferable to irradiate the bone with plasma while ensuring sufficient gaps between the bone fragments before carrying out reduction procedures. This promotes bone regeneration of cancellous bone and shortens the total time required for fracture healing. On the other hand, when plasma irradiation has little effect on cancellous bone and contributes greatly to bone regeneration of cortical bone, it is preferable to irradiate the bone with plasma while carrying out reduction procedures, since this provides a stable operation.
[0062] In the above embodiment, the plasma supply step is performed by continuously irradiating the plasma for a predetermined period of time. In a modified example, the plasma may be irradiated intermittently during the predetermined period of time. For example, the plasma supply may be temporarily stopped every few minutes.
[0063] In the above embodiment, helium is used as the carrier gas, but argon, neon, xenon, or other rare gases may be used, or nitrogen or other gases may be used. Alternatively, the carrier gas may not be a single type of gas, but may be a mixture of multiple types of gases. For example, a mixture of helium and oxygen may be used as the carrier gas.
[0064] The present invention is not limited to the above-mentioned embodiment and modifications, and the components can be modified without departing from the spirit of the present invention. Various inventions can be formed by appropriately combining multiple components disclosed in the above-mentioned embodiment and modifications. Also, some components can be deleted from all the components shown in the above-mentioned embodiment and modifications. [Explanation of symbols]
[0065] 1 bone regeneration promotion device, 10 plasma device, 12 gas supply device, 14 control unit, 20 gas supply pipe, 22 electrode, 24 voltage application device, 26 outlet, 28 gas tube, 29 housing, 30 gas tank, 32 piping, 34 control valve, AT bone tissue, B living bone, B1 bone fragment, B10 ulna, BT bone tissue, PJ plasma jet, ST scar tissue, X target site.
Claims
1. A target site identifying step of identifying a site of a fracture or bone defect in a non-human animal; a plasma supplying step of irradiating only plasma toward the portion under atmospheric pressure; Equipped with A method for promoting bone regeneration in a non-human animal, characterized in that the plasma supply step limits the irradiation of the plasma to a period during which capillary bleeding is occurring at the site as part of the process of hematoma formation at the site.
2. The plasma supply step includes: Supplying a plasma jet toward the portion; The method for promoting bone regeneration in a non-human animal according to claim 1, characterized in that the flow rate of the plasma jet is adjusted depending on the size of the site.
3. 3. The method for promoting bone regeneration in a non-human animal according to claim 2, wherein the plasma supply step adjusts the length of the plasma jet depending on the depth of the site.
4. 4. The method for promoting bone regeneration in a non-human animal according to any one of claims 1 to 3, characterized in that in the plasma supplying step, the plasma irradiation time is adjusted depending on the size of the site.
Citation Information
Patent Citations
Implant
JP2011229908A
Method for modifying artificial bone containing bioceramics, and artificial bone modified by this method
JP2013215240A
System for Plasma Therapy Using a Directional Dielectric Barrier Discharge Energy System
JP2017510050A
UV ozone-plasma composite treatment method and treatment apparatus
JP2019017387A
Palpation method for forming bone with bioplasma
KR1020170140523A